US Measles Cases Reach Their Highest Level in More Than 35 Years
US measles cases have climbed to their highest annual level in more than 35 years, turning a disease once considered largely controlled in the United States into a renewed public-health concern. The CDC reported 2,566 confirmed cases as of August 13, 2026, already above the 2,289 cases recorded during all of 2025.
The numbers matter because measles is not simply a childhood rash. It is one of the most contagious infectious diseases known, can cause pneumonia and brain inflammation, and spreads especially quickly where vaccination coverage has fallen. The latest CDC data show cases reported across 47 U.S. jurisdictions and that 94% of confirmed infections are associated with outbreaks.
The rise in US measles cases also comes at an awkward moment for a country that declared measles eliminated in 2000. Elimination does not mean zero cases forever. It means there is no continuous home-grown transmission over a sustained period. Imported infections can still trigger outbreaks, particularly when the virus reaches communities with immunity gaps.
So why are US measles cases rising again, what does the 35-year high actually mean, and how worried should families be? The answer involves declining MMR coverage, international travel, clusters of unvaccinated people and the extraordinary ability of measles to spread.
US Measles Cases in 2026: The Numbers at a Glance
The CDC updates its data on US measles cases weekly. Its August 14 update, reflecting confirmed reports through noon on August 13, put the 2026 total at 2,566.
| Measure | Latest reported figure |
|---|---|
| Confirmed U.S. measles cases in 2026 | 2,566 |
| U.S. cases in all of 2025 | 2,289 |
| Cases linked to outbreaks in 2026 | 2,407, or 94% |
| Outbreaks reported in 2026 | 38 |
| Jurisdictions reporting U.S. resident cases | 47 |
| International visitors included in 2026 total | 16 |
| Kindergarten MMR coverage, 2024–25 | 92.5% |
| Community-immunity target | Above 95% |
| Two-dose MMR effectiveness | About 97% |
US measles cases are already 277 higher than the entire 2025 count, and the year is far from over. That makes the resurgence more than a statistical curiosity. It shows that the conditions allowing measles to spread have become more favorable in a number of communities.
1. The 35-Year High Is a Warning About Lost Ground
The most striking fact about US measles cases is how quickly the country has moved backward.
US measles cases numbered only 285 in 2024. In 2025, that jumped to 2,289. By August 13, 2026, the total had reached 2,566. The current count is the highest annual total in more than 35 years.
That comparison needs context. Before the first measles vaccine was licensed in 1963, the CDC estimates that 3 million to 4 million people were infected in the United States each year, although only a fraction were formally reported. In the decade before vaccination, an average of about 549,000 cases and 495 deaths were reported annually.
Vaccination transformed that picture. By 2000, measles was declared eliminated in the United States.
The return of thousands of US measles cases does not mean the country has returned to the pre-vaccine era. It does show that elimination is not self-sustaining. It depends on maintaining enough immunity that imported cases cannot establish long chains of transmission.
The same lesson appears in other infectious-disease emergencies. The News Ink has covered how vaccination and rapid public-health response shape the course of a severe Ebola outbreak. Measles is different biologically, but the broader principle is similar: prevention becomes much harder once transmission is already spreading through vulnerable communities.
2. Falling MMR Coverage Has Created More Openings for Measles
The clearest structural reason behind rising US measles cases is declining vaccination coverage.
The CDC says MMR coverage among U.S. kindergartners fell from 95.2% in the 2019–20 school year to 92.5% in 2024–25. That may look like a small difference, but measles is so contagious that relatively small immunity gaps can matter. The decline left an estimated 286,000 kindergartners at risk during the 2024–25 school year.
Public-health authorities generally aim for more than 95% measles vaccine coverage because that level makes sustained transmission much harder. National averages can also hide local weakness. A state may appear well vaccinated overall while individual counties, schools or communities have much lower coverage.
That is why US measles cases often cluster rather than spread evenly across the country.
The CDC’s current data show that 93% of 2026 cases are in people listed as unvaccinated or with unknown vaccination status. The agency combines those categories in rapid national reporting because some cases are confirmed before complete immunization records can be obtained. That means the figure should not be read as proof that every person in the group was unvaccinated. It does, however, show that documented protection is missing in the overwhelming majority of reported cases.
MMR remains highly effective. According to the CDC’s vaccine recommendations, one dose is about 93% effective at preventing measles and two doses are about 97% effective.
For readers interested in how vaccination fits into the wider prevention of serious infections, our meningitis guide explains a different disease where vaccination can also play an important preventive role.
3. Measles Spreads Faster Than Many People Realize
The rise in US measles cases makes more sense once the virus’s contagiousness is understood.
According to the CDC’s clinical overview, as many as nine out of 10 susceptible people who have close contact with someone with measles will become infected. The virus spreads through respiratory droplets and through the air when an infected person breathes, coughs or sneezes.
Even more importantly, measles virus can remain infectious in the air for up to two hours after an infected person has left an area.
That creates a very different outbreak challenge from illnesses that require prolonged direct contact.
A person can be exposed in a waiting room, school, airport, household or other shared indoor space without realizing that someone with measles had recently been there. People are also contagious before the classic rash is fully visible, which gives the virus time to move before a case is recognized.
The CDC’s symptom guidance says symptoms generally begin seven to 14 days after infection. They often include:
- high fever;
- cough;
- runny nose;
- red or watery eyes;
- small white Koplik spots inside the mouth;
- a red rash that usually begins around the face and moves downward.
The rash typically appears several days after the first symptoms. A person’s fever can also rise sharply when the rash develops.
These symptoms overlap with other respiratory illnesses early on, making travel history, vaccination status and known exposure important information for clinicians.
The speed of transmission helps explain why 94% of current US measles cases are associated with outbreaks rather than isolated infections. Once measles reaches a pocket of people without immunity, public-health teams may need to trace contacts rapidly, verify vaccination records and notify schools, healthcare facilities and other places where exposure may have occurred.
The challenge resembles other outbreak-control situations in one respect: transmission can turn an individual diagnosis into a community problem. A recent norovirus outbreak covered by The News Ink illustrates how quickly infection-control measures can affect entire groups, even though norovirus and measles spread differently.
4. International Travel Keeps Reintroducing the Virus
The United States eliminated continuous measles transmission, but the virus was never eliminated globally.
That distinction is central to understanding US measles cases.
US measles cases can begin with infections acquired abroad because measles continues to circulate in many regions of the world. Infected travelers can become sick overseas and return to the United States before symptoms are obvious. If they enter a community with high vaccination coverage, transmission may stop quickly. If they enter a community with larger immunity gaps, one imported infection can seed a wider outbreak.
Global travel therefore connects U.S. measles risk with vaccination conditions elsewhere.
The World Health Organization estimates that measles caused around 95,000 deaths globally in 2024. WHO also estimates that vaccination prevented approximately 59 million deaths between 2000 and 2024, highlighting both the effectiveness of immunization and the consequences when coverage is inadequate.
To reduce travel-linked US measles cases, the CDC advises international travelers to make sure they are protected before departure. Its travel guidance recommends two MMR doses for the best protection for most eligible travelers and includes special recommendations for infants aged 6 to 11 months traveling internationally.
This does not mean international visitors are driving the U.S. resurgence. The CDC says only 16 of the 2,566 cases in its current national total were reported among international visitors.
The more important pathway is that U.S. residents can become infected during international travel and then expose people after returning home.
With global measles activity elevated, every local immunity gap becomes more consequential.
5. Measles Can Cause Serious Complications
One reason the increase in US measles cases deserves attention is that the disease is often underestimated.
For many people, measles is remembered as a fever followed by a rash. Most patients recover, but the infection can also lead to complications that are particularly dangerous for young children, pregnant people, adults over 20 and people with weakened immune systems.
The CDC estimates that about one in five unvaccinated people in the United States who develop measles will be hospitalized. About one in 20 children with measles develops pneumonia, and about one in 1,000 develops encephalitis, or swelling of the brain. Roughly one to three of every 1,000 infected children may die from respiratory or neurological complications.
There is also a rare long-term complication called subacute sclerosing panencephalitis, or SSPE. It can develop years after a person appears to have recovered and is a progressive, fatal disease of the central nervous system.
Researchers have also studied “immune amnesia,” a phenomenon in which measles damages immune memory and can leave a person more vulnerable to other infections for months or even years after recovery.
Those risks help explain why public-health agencies do not treat a surge in US measles cases as merely an inconvenience.
The broader lesson is that vaccine-preventable infections can have consequences far beyond the initial symptoms. The News Ink’s coverage of vaccine research looks at how scientists are also trying to improve protection against other viral threats, although measles already has a long-established and highly effective vaccine.
6. America’s Measles-Elimination Status Is Under Pressure
The rise in US measles cases has revived an important technical issue: whether the United States can continue to maintain its measles-elimination status.
For public-health purposes, elimination does not mean a country never sees another case. It means endemic transmission has been interrupted, even though imported infections and limited outbreaks can still occur.
The United States achieved that status in 2000.
The rise in US measles cases does not by itself erase that status. Sustained transmission, however, creates a risk that elimination could eventually be lost.
The Pan American Health Organization said in March that the review of measles-elimination status for the United States and Mexico would take place in November 2026.
That review matters because rising US measles cases test whether public-health systems are preventing imported infections from becoming continuous domestic transmission.
High US measles cases do not automatically mean the United States has lost elimination. The CDC continues to describe measles as eliminated in the country while documenting large outbreaks and rising case counts. The formal review process will examine transmission patterns rather than simply the national number.
Still, the scale of US measles cases makes the discussion much more serious than it was a few years ago.
In 2019, the United States came close to losing elimination status after outbreaks pushed the annual total above 1,200 cases. The country maintained its status after those transmission chains were stopped. The 2026 total is already roughly double the 2019 figure.
The crucial question now is not just how many people become infected, but whether individual chains of transmission can be interrupted.
7. The Cost of an Outbreak Goes Beyond the Patient
US measles cases also carry a financial cost that is easy to overlook.
When one person is diagnosed, public-health departments may have to identify everyone who shared an exposure setting, check immunity records, arrange testing, advise families, contact schools and employers, coordinate isolation and provide vaccination or other preventive measures where appropriate.
A single outbreak can consume thousands of staff hours.
A study of a 2025 New Mexico outbreak estimated the total economic impact at about $5.4 million when public-health response, medical expenses and lost productivity were included. Public-health response and vaccination activities accounted for roughly $3.2 million of that total.
The point is not that every outbreak costs the same amount. Size, location and exposure settings can change the bill dramatically. It does show why prevention is generally much less disruptive than outbreak control.
Healthcare settings face an additional challenge because measles is airborne. A patient who arrives without warning can expose other patients, staff and visitors. Clinics may need special infection-control procedures and rapid coordination with health departments.
This is one reason people who suspect measles are commonly advised to call a healthcare provider before simply entering a clinic or emergency department. Advance warning allows the facility to reduce the risk of exposing others. The CDC specifically advises people who believe they or their child may have been exposed to contact a healthcare provider promptly.
What Families Should Understand About MMR Protection
The current rise in US measles cases can make vaccination information feel complicated, but the routine recommendations are relatively straightforward.
The CDC recommends two MMR doses for children, normally:
- the first dose at 12 to 15 months;
- the second dose at 4 to 6 years.
The second dose can be given earlier in certain circumstances as long as minimum intervals are respected. Recommendations differ for some international travelers, healthcare workers and people exposed during outbreaks.
Most adults do not automatically need repeated MMR boosters. The appropriate number of doses depends on age, risk factors and evidence of immunity.
The CDC lists written vaccination records, laboratory evidence of immunity, laboratory-confirmed previous disease and birth before 1957 as forms of presumptive evidence in routine circumstances, with additional considerations for some healthcare personnel.
The combined MMR vaccine has decades of safety data behind it. The CDC’s vaccine safety information states that common reactions are generally mild and that scientific studies have not found a causal link between MMR vaccination and autism.
People with specific health conditions, pregnancy or concerns about their vaccination history should discuss their situation with a qualified healthcare professional rather than relying on general online guidance.
What Happens Next
The direction of US measles cases through the rest of 2026 will depend on whether current outbreaks are brought under control and whether new importations reach vulnerable communities.
Several indicators will matter:
- whether weekly case growth slows;
- whether large transmission chains are closed;
- whether vaccination rises in outbreak areas;
- whether school-age MMR coverage improves;
- whether travel-related cases seed additional outbreaks;
- and what PAHO concludes during the elimination-status review expected in November.
The CDC also notes that measles is not strictly seasonal, although high-travel periods and settings where unvaccinated people spend time together can create opportunities for spread.
The current US measles cases count of 2,566 should therefore not be treated as the final 2026 figure.
The more important question is whether the conditions behind the surge change.
Frequently Asked Questions
Are US measles cases really at a 35-year high?
Yes. The CDC reported 2,566 confirmed cases as of August 13, 2026. That is the highest annual U.S. total in more than 35 years and is already higher than the 2,289 cases reported during all of 2025.
Can vaccinated people still get measles?
Yes, but it is uncommon. The CDC estimates that one MMR dose is about 93% effective and two doses are about 97% effective. Breakthrough infections can occur, especially during intense outbreaks.
How long can measles stay in the air?
The CDC says measles virus can remain infectious in the air for up to two hours after an infected person leaves an area.
What should someone do after a possible measles exposure?
The CDC advises people who think they or their child may have been exposed to contact a healthcare provider promptly. Calling ahead is important because healthcare facilities may need to take precautions to avoid exposing other patients.
Has the United States lost measles-elimination status?
Not automatically. The United States has been considered to have eliminated endemic measles since 2000. PAHO has said the country’s status will be reviewed in November 2026 as authorities assess ongoing transmission.
Conclusion
The surge in US measles cases is a reminder that successful disease elimination has to be maintained.
The United States still has an effective vaccine, strong surveillance systems and decades of experience controlling measles. What has changed is the number of opportunities the virus has to spread. Kindergarten MMR coverage has fallen below the 95% target nationally, some communities have much larger immunity gaps, and global measles activity keeps creating opportunities for importation.
With US measles cases at 2,566 already in 2026, the country has reached its highest annual measles total in more than 35 years. Most current cases are linked to outbreaks, and the overwhelming majority involve people with no documented vaccination or unknown vaccination status.
The next phase will depend on whether health departments can interrupt those transmission chains and whether communities rebuild the vaccination coverage that made elimination possible in the first place.
The story of US measles cases is therefore not simply about one bad year. It is about how quickly a highly contagious virus can exploit small gaps in population immunity, and how much effort is required to restore protection once those gaps become visible.
This article is for general information only. It is not a substitute for professional medical advice, diagnosis or treatment.
Follow The News Ink
Stay connected with The News Ink for coverage of health, science, technology, world news and sports.
Follow us on X, Instagram, Threads, TikTok, Bluesky and Mastodon.
For longer-form coverage and discussion, follow The News Ink on Medium, Substack and Quora, or find visual stories on Pinterest.
